← 產業報告目錄
Cancer Stem Cells Market Size, Share & Trends Analysis Report, By Type of Cancer (Breast Cancer, Lung Cancer, Brain Cancer, Prostate Cancer, Colorectal Cancer, Others), By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Stem Cell Transplantation, Others), By Biomarker Type (CD44, CD133, ALDH1, Others), By End-user (Hospitals, Cancer Research Institutes, Biotechnology Companies, Academic Research Institutes), By Region, Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-23頁數 180報告編號 INSIGHTACE-81fca26e2e
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Cancer Stem Cells Market on a global scale was estimated at USD 4.3 Bn in 2024 and is expected to attain USD 12.6 Bn by 2034, with a projected CAGR of 11.4% between 2025 and 2034.
Cancer Stem Cells encompasses challenges.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cancer Stem Cells Market Snapshot
Chapter 4. Global Cancer Stem Cells Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Cancer Estimates & Trend Analysis
5.1. by Type of Cancer & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Cancer:
5.2.1. Breast Cancer
5.2.2. Lung Cancer
5.2.3. Brain Cancer
5.2.4. Prostate Cancer
5.2.5. Colorectal Cancer
5.2.6. Others
Chapter 6. Market Segmentation 2: by Treatment Type Estimates & Trend Analysis
6.1. by Treatment Type & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Treatment Type:
6.2.1. Chemotherapy
6.2.2. Immunotherapy
6.2.3. Targeted Therapy
6.2.4. Stem Cell Transplantation
6.2.5. Others
Chapter 7. Market Segmentation 3: by Biomarker Type Estimates & Trend Analysis
7.1. by Biomarker Type & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Biomarker Type:
7.2.1. CD44
7.2.2. CD133
7.2.3. ALDH1
7.2.4. Others
Chapter 8. Market Segmentation 4: by End-User Estimates & Trend Analysis
8.1. by End-User & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-User:
8.2.1. Hospitals
8.2.2. Cancer Research Institutes
8.2.3. Biotechnology Companies
8.2.4. Academic Research Institutes
Chapter 9. Cancer Stem Cells Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2021-2034
9.1.2. North America Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2021-2034
9.1.3. North America Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Biomarker Type, 2021-2034
9.1.4. North America Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.1.5. North America Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2021-2034
9.2.2. Europe Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2021-2034
9.2.3. Europe Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Biomarker Type, 2021-2034
9.2.4. Europe Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.2.5. Europe Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2021-2034
9.3.2. Asia Pacific Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2021-2034
9.3.3. Asia-Pacific Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Biomarker Type, 2021-2034
9.3.4. Asia Pacific Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.3.5. Asia Pacific Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2021-2034
9.4.2. Latin America Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2021-2034
9.4.3. Latin America Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Biomarker Type, 2021-2034
9.4.4. Latin America Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.4.5. Latin America Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer, 2021-2034
9.5.2. Middle East & Africa Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2021-2034
9.5.3. Middle East & Africa Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by Biomarker Type, 2021-2034
9.5.4. Middle East & Africa Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.5.5. Middle East & Africa Cancer Stem Cells Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific Inc.
10.2.2. Merck KGaA
10.2.3. STEMCELL Technologies Inc.
10.2.4. Sino Biological Inc.
10.2.5. Celgene Corporation
10.2.6. AbbVie Inc.
10.2.7. Incyte Corporation
10.2.8. Novartis AG
10.2.9. Pfizer Inc.
10.2.10. Bionique Testing Laboratories Inc.
10.2.11. Miltenyi Biotec GmbH
10.2.12. Lonza Group AG
10.2.13. OncoMed Pharmaceuticals Inc.
10.2.14. Daiichi Sankyo Company Limited
10.2.15. Verastem Inc.
10.2.16. Others
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們